Cofounder and Director | Cancer Dependency Map Consortium #depmap | Cancer Target Discovery @Broad Institute https://target-discovery.depmap.org/

Assistant Professor Instituto Superior Técnico (IST) and INESC-ID https://web.tecnico.ulisboa.pt/emanuel.v.goncalves/

Cambridge-based data scientist modelling drug combinations to improve patient outcomes. Views my own, she/her 🇪🇺

Chief Science Officer, Break Through Cancer; Principal Investigator, Koch Institute, MIT - boehmlab.org

we mix informatics/biology/functional-genomics to identify new therapeutic targets/markers, for cancer and other human diseases. we ❤️ CRISPR, statistics and ML

Group Leader, UCL Cancer Institute. Studying how different cell-types collaborate to drive cancer | http://tape-lab.com

Assoc Prof, MD Anderson. Functional genomics, CRISPR/Cas12a genetic interactions & synthetic lethality, history, politics, snark.

Group Leader at EMBL-EBI. Our group uses interdisciplinary approaches including network analysis, omics integration and mathematical modelling to study the context specific regulation of human cell signalling.

Public-private partnership using human genetics and genomics data for systematic drug target identification and prioritisation. http://blog.opentargets.org

We’re the world's leading independent cancer charity dedicated to saving lives through research, influence and information. linktr.ee/cr_uk

Cancer Research UK Scotland Institute (formerly the CRUK Beatson Institute). Our Mission: Cancer discovery for patient benefit. www.crukscotlandinstitute.ac.uk

We are a leading Cancer Research Institute within The University of Manchester, funded by Cancer Research UK (@cancerresearchuk.org) https://www.cruk.manchester.ac.uk/

A multidisciplinary community of researchers with the mission to better understand the roots of disease and narrow the gap between new biological insights and impact for patients. Broadinstitute.org

The best of FT journalism, including breaking news and analysis. https://www.ft.com The users this account follows are verified FT staff or contributors.

Associate professor at ETH Zurich, studying the cellular consequences of genetic variation. Affiliated with the Swiss Institute of Bioinformatics and a part of the LOOP Zurich.

Studying cancer genomics in Latin America. PI @liigh-unam.bsky.social | Int'l fellow @sangerinstitute.bsky.social. Views my own. She/her/hers

USA->UK->Finland. Posting about 'omics technologies and the great outdoors (among other things).

Scientist developing AI for oncology. Division head at the German Cancer Research Centre DKFZ. Prof at the University of Heidelberg, Germany. Previously at EMBL-EBI and Wellcome Sanger Institute. Alumnus of ETH Zurich.

Systems biology | Bioinformatics | Cancer | Genetic interactions https://cancerdata.ucd.ie/ (he / him)

Professor at UCSF. Molecular/cellular mechanisms of brain disease. Functional Genomics. Diversity & Inclusion. 🏳️‍🌈 he/him

Scientist: durocherlab.org @ Lunenfeld-Tanenbaum Research Institute, Toronto. Founder: Repare Therapeutics & Induxion Therapeutics

Associate Professor | Functional Genomics | UMass Chan Medical School

Cancer Research UK Career Development Fellow at the Wellcome Sanger Institute - gene editing - drug resistance - cancer

Research group leader @humantechnopole, cancer researcher, algorithm designer, dad, cook, failed singer, resting runner 😉

Functional genomics @ Broad Institute. Screen all the things!

official Bluesky account (check username👆) Bugs, feature requests, feedback: support@bsky.app